UPDATE: Citi Downgrades Blueprint Medicines (BPMC) to Sell
Tweet Send to a Friend
(Updated - June 9, 2022 4:45 PM EDT)
Citi analyst David Lebowitz downgraded Blueprint Medicines (NASDAQ: BPMC) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst David Lebowitz downgraded Blueprint Medicines (NASDAQ: BPMC) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
